17 employees
Opna Bio is a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics.
2022
$38M
from 3 investors over 3 rounds
Opna Bio raised $38M on November 21, 2022
Investors: Northpond Ventures, Longitude Capital and Menlo Ventures